| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |